# Effects of Repeat Dosing of GSK1521498

> **NCT00976105** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 49 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Zolpidem or placebo - Hypnotic drug given for sleep disorders
- **DRUG:** GSK1521498 or placebo

## Key facts

- **NCT ID:** NCT00976105
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09-22
- **Primary completion:** 2010-03-09
- **Final completion:** 2010-03-09
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2017-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00976105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00976105, "Effects of Repeat Dosing of GSK1521498". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00976105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*